ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
UK biotech gets grant for further trial of osteoarthritis drug
February 21, 2019UK biotech AKL Research and Development (AKLRD) has received a grant from a UK government-backed innovation body to develop its potentially “game changing” osteoarthritis drug. -
Regeneron halts high doses of phase 3 osteoarthritis drug fasinumab amid risk-benefit concerns
May 04, 2018Regeneron has halted the higher-dose arms of its phase 3 fasinumab trials on the recommendation of a data monitoring committee. The committee made the call after assessing the risk-benefit profile of the osteoarthritis regimens based on data generated to
Pharma Sources Insight January 2025
